Key result
Percutaneous PFO closure is associated with a transient ~10 ms increase in P wave dispersion.
Why the study?
Controversy exists surrounding the risk of AF following percutaneous patent foramen ovale closure.
Does percutaneous PFO closure induce electrical remodeling as measured by surface ECG in patients with PFO?
Cohort (n=246)
No
Does percutaneous PFO closure induce electrical remodeling as measured by surface ECG in patients with PFO?
Mean Difference: 10.3 (95% CI 9.57–10.98)
p-value: p=<0.001
Percutaneous PFO closure induces transient elevation in P wave dispersion and sustained PR interval shortening, suggesting electrical remodeling, though without significant short-term arrhythmogenic consequences.
Background: Controversy exists around AF risk after patent foramen ovale (PFO) closure. This study characterised dynamic ECG changes over 6 months after Amplatzer closure, focusing on electrical remodelling. Methods: In all, 246 PFO patients underwent serial ECGs (P wave dispersion [PWD], PR interval, QRS, corrected QT interval [QTc]) and echocardiography before PFO closure and 24 hours and 1, 3 and 6 months after closure. Temporal changes were analysed. Subgroup analyses evaluated ECG changes according to comorbidity (migraine or cerebral infarction). Results: PWD increased significantly at 24 hours and peaked at 1 month, remaining elevated compared with baseline at 6 months (p<0.001). Of all patients, 5.3% had PWD ≥40 ms. The PR interval was significantly shortened after PFO closure, with this persisting at 6 months (p<0.001). AF occurred in six (2.4%) patients and supraventricular tachycardia occurred in eight (3.3%). QRS and QTc were stable. With regard to cardiac structure/function, no significant echocardiographic changes were seen from before to after PFO closure. In subgroups analyses, PR shortening was greater in patients with migraine than in those with cerebral infarction (p<0.001). Conclusion: PFO closure induced a transient elevation in PWD and sustained PR shortening. Under limited spot ECG monitoring, no clinically significant arrhythmias or structural changes were detected. However, extended surveillance is warranted to evaluate potential late-onset arrhythmogenic sequelae.
No takes yet. Share an insight, caveat, or question.
Yue et al. (2026) conducted a cohort in Patent foramen ovale (PFO) (n=246). Percutaneous PFO closure was evaluated on P wave dispersion (PWD) change at 1 month (mean increase of 10.3 ms, 95% CI 9.57-10.98, p=<0.001). Percutaneous PFO closure induced a transient elevation in P wave dispersion, peaking at 1 month with a 10.3 ms increase, and sustained PR interval shortening over 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: